Cargando…
T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter
The aim of the study was to investigate the signal-intensity-(SI)-ratio changes in the basal ganglia, the pulvinar thalami (PN), and the dentate nucleus (DN) using frontal white matter (FWM) as reference area, in patients with multiple sclerosis after frequent administrations of gadobutrol. A contro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237839/ https://www.ncbi.nlm.nih.gov/pubmed/30442977 http://dx.doi.org/10.1038/s41598-018-35186-w |
_version_ | 1783371252657815552 |
---|---|
author | Kelemen, Peter Alaoui, Jamila Sieron, Dominik Chan, Andrew Kamm, Christian P. Heldner, Mirjam R. Gralla, Jan Wiest, Roland Verma, Rajeev K. |
author_facet | Kelemen, Peter Alaoui, Jamila Sieron, Dominik Chan, Andrew Kamm, Christian P. Heldner, Mirjam R. Gralla, Jan Wiest, Roland Verma, Rajeev K. |
author_sort | Kelemen, Peter |
collection | PubMed |
description | The aim of the study was to investigate the signal-intensity-(SI)-ratio changes in the basal ganglia, the pulvinar thalami (PN), and the dentate nucleus (DN) using frontal white matter (FWM) as reference area, in patients with multiple sclerosis after frequent administrations of gadobutrol. A control group (group I) was compared to three stratified patient groups (group II: mean applications of gadobutrol 3.7; group III: 7.5 applications; group IV: 13.8 applications). SI-ratios of the pallidum, putamen, caudate nucleus, and pulvinar thalami were calculated with: 1. FWM, and 2. PN. DN-to-pons and DN-to-FWM ratios were also calculated. The most significant SI-ratio-changes were found by comparing group I and IV for both reference values. However, by using FWM as reference an SI-ratio increase was observed, while an SI-ratio decrease was seen if referenced to the PN. DN-to-FWM showed an SI-ratio increase, too. The PN revealed a significant SI-ratio increase itself, correlating with the number of gadolinium applications, when referenced to FWM. Therefore, SI-ratio calculations using the thalamus as reference might be flawed. In addition, a minor gadolinium accumulation is possible, if FWM was used as reference area. Further studies are necessary to verify our results. |
format | Online Article Text |
id | pubmed-6237839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62378392018-11-23 T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter Kelemen, Peter Alaoui, Jamila Sieron, Dominik Chan, Andrew Kamm, Christian P. Heldner, Mirjam R. Gralla, Jan Wiest, Roland Verma, Rajeev K. Sci Rep Article The aim of the study was to investigate the signal-intensity-(SI)-ratio changes in the basal ganglia, the pulvinar thalami (PN), and the dentate nucleus (DN) using frontal white matter (FWM) as reference area, in patients with multiple sclerosis after frequent administrations of gadobutrol. A control group (group I) was compared to three stratified patient groups (group II: mean applications of gadobutrol 3.7; group III: 7.5 applications; group IV: 13.8 applications). SI-ratios of the pallidum, putamen, caudate nucleus, and pulvinar thalami were calculated with: 1. FWM, and 2. PN. DN-to-pons and DN-to-FWM ratios were also calculated. The most significant SI-ratio-changes were found by comparing group I and IV for both reference values. However, by using FWM as reference an SI-ratio increase was observed, while an SI-ratio decrease was seen if referenced to the PN. DN-to-FWM showed an SI-ratio increase, too. The PN revealed a significant SI-ratio increase itself, correlating with the number of gadolinium applications, when referenced to FWM. Therefore, SI-ratio calculations using the thalamus as reference might be flawed. In addition, a minor gadolinium accumulation is possible, if FWM was used as reference area. Further studies are necessary to verify our results. Nature Publishing Group UK 2018-11-15 /pmc/articles/PMC6237839/ /pubmed/30442977 http://dx.doi.org/10.1038/s41598-018-35186-w Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Kelemen, Peter Alaoui, Jamila Sieron, Dominik Chan, Andrew Kamm, Christian P. Heldner, Mirjam R. Gralla, Jan Wiest, Roland Verma, Rajeev K. T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter |
title | T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter |
title_full | T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter |
title_fullStr | T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter |
title_full_unstemmed | T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter |
title_short | T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter |
title_sort | t1-weighted grey matter signal intensity alterations after multiple administrations of gadobutrol in patients with multiple sclerosis, referenced to white matter |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237839/ https://www.ncbi.nlm.nih.gov/pubmed/30442977 http://dx.doi.org/10.1038/s41598-018-35186-w |
work_keys_str_mv | AT kelemenpeter t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT alaouijamila t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT sierondominik t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT chanandrew t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT kammchristianp t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT heldnermirjamr t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT grallajan t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT wiestroland t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter AT vermarajeevk t1weightedgreymattersignalintensityalterationsaftermultipleadministrationsofgadobutrolinpatientswithmultiplesclerosisreferencedtowhitematter |